Status:
TERMINATED
Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers
Lead Sponsor:
Stanford University
Conditions:
Gastrointestinal Cancer
Colorectal Cancer
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of the study is to determine whether standardized implementation of a scripted template for discussing important issues that arise near the end of life improves the care of those who have ...
Detailed Description
Primary Objective: To determine whether the Serious Illness Conversation Guide will improve the consistency with which providers have and document conversations regarding patients' goals and prioritie...
Eligibility Criteria
Inclusion
- Patients with metastatic colorectal cancer whose tumor has progressed on both FOLFOX and FOLFIRI.
- Exception: Patients with metastatic colorectal cancer whose tumors demonstrate a BRAF V600E mutation may be enrolled regardless of prior chemotherapy.
- Exception: Patients whose tumors are MSI-H must have experience progression through immunotherapy in addition to the therapies mentioned above.
- Patients with metastatic pancreatic adenocarcinoma.
- Patients with metastatic gastric or esophageal cancer whose tumor has progressed through first-line chemotherapy of any type.
- Patients with metastatic cholangiocarcinoma whose tumor has progressed through first-line chemotherapy of any type.
- Patients with metastatic hepatocellular carcinoma whose tumor has progressed through PD1 blockade.
- Patients with metastatic high-grade neuroendocrine tumor.
- A patient with a metastatic GIST that has progressed through first-line tyrosine kinase inhibitor.
- Expected life expectancy of at least one month
Exclusion
- Any patient not meeting the above criteria
- Non-English speaking patients
Key Trial Info
Start Date :
September 16 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 11 2020
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04077372
Start Date
September 16 2019
End Date
October 11 2020
Last Update
January 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford Cancer Center
Stanford, California, United States, 94304